← 返回首页
markets
Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO
📍 feeds.bloomberg.com
⏰ 2026-04-08 20:42
🌏 US
Avalyn Pharma Inc., a biopharma company developing inhaled treatments for respiratory diseases, filed for a US initial public offering.